
    
      The study was designed as a prospective, delayed-entry randomized pilot trial.
      Regression-adjusted difference in means were used to examine the intervention's effectiveness
      with respect to PTSD symptomatology (primary outcome) as well as depression, perceptions of
      cognitive failures, social functioning and isolation, and health-related quality of life
      (secondary outcomes).
    
  